Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nanoscale ; 15(8): 3940-3951, 2023 Feb 23.
Article in English | MEDLINE | ID: mdl-36723206

ABSTRACT

Hydroxyapatite (HA) is a biomimetic biomaterial that has been widely used in bone repair for many years. However, the increased risk of infection after surgery and long-time tracing for the material distribution and degradation during bone reconstruction remain challenges in the clinic. Zinc (Zn) is considered as an indispensable microelement for humans and is characterized with antibacterial action and osteogenic activity. Terbium (Tb), a rare-earth element, emits stable fluorescence under ultraviolet light. Here, Tb3+/Zn2+ co-doped hydroxyapatite (HA:Tb/Zn) was prepared to synchronously realize the antibacterial effect, osteogenic activity, and long-time tracing property. We found that HA:Tb/Zn had a strong antibacterial effect on both Gram-positive and Gram-negative clinical infectious bacteria, as well as improved osteogenic activity. HA:Tb/Zn also displayed stable green fluorescence in vitro and in vivo, which indicated great potential for recognizing the material changes during the bone reconstruction process. The combination of the ternary functions is of great significance to control the overuse of antibiotics and realize long-time tracing, and provide a versatile design on biomaterials in bone repair.


Subject(s)
Durapatite , Terbium , Humans , Biocompatible Materials , Zinc , Anti-Bacterial Agents
2.
Carbohydr Polym ; 241: 116386, 2020 Aug 01.
Article in English | MEDLINE | ID: mdl-32507188

ABSTRACT

Treatment of oral pathogens is important for both oral and systemic health. The antimicrobial activity of chitosan (CS)-based scaffolds either loading antibiotics or compositing with other agents are well documented. However, the intrinsic antibacterial activity of CS scaffolds alone has never been reported. Herein, we fabricated the non-crosslinked CS scaffold and investigated its antibacterial activity against typical oral pathogens, Gram-negative Porphyromonas gingivalis and Gram-positive Streptococcus mutans. We found both pathogens were completely killed by 1 mg CS scaffolds at 6 h, due largely to the CS-induced time-dependent bacteria clustering. Interestingly, ß-glycerophosphate crosslinked scaffolds showed no antibacterial activity. In conclusion, the bactericidal activity of CS scaffolds alone is reported for the first time. Together with the biodegradability, physical stability, biocompatibility and great antibacterial activity, the non-crosslinked CS scaffolds may have great potentials not only in treating oral diseases but also in wound healing and tissue engineering.


Subject(s)
Anti-Infective Agents/pharmacology , Biocompatible Materials/pharmacology , Chitosan , Porphyromonas gingivalis/drug effects , Streptococcus mutans/drug effects , Tissue Scaffolds , Cells, Cultured , Chitosan/analogs & derivatives , Chitosan/pharmacology , Epithelial Cells , Humans
3.
Colloids Surf B Biointerfaces ; 191: 111009, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32305622

ABSTRACT

The antibiotics-independent antimicrobial activity of graphene oxide (GO) is of great importance since antibiotic therapy is facing great challenges from drug resistance. However, the relations of GO size with its antimicrobial activity and how the size regulates the antibacterial mechanisms are still unknown. Herein, we fabricated four GO suspensions with different sizes and demonstrated the parabolic relationship between GO size and its antibacterial activity against the Gram-positive cariogenic bacterium Streptococcus mutans. More interestingly, we found out how GO size regulated the nano-bio interaction-based physical antibacterial mechanisms. Increasing the size reduced the cutting effect but enhanced the cell entrapment effect, and vice versa. In conclusion, GO size affects its edge density and lateral dimension, further regulates its physical antibacterial mechanisms in different orientations and ultimately determines its activity. These findings provide a deep understanding of GO antibacterial property and may guide the design and development of GO for clinical use.


Subject(s)
Anti-Bacterial Agents/pharmacology , Graphite/pharmacology , Nanoparticles/chemistry , Streptococcus mutans/drug effects , Anti-Bacterial Agents/chemistry , Graphite/chemistry , Microbial Sensitivity Tests , Particle Size , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL
...